ALX Oncology Holdings Inc
NASDAQ:ALXO
Income Statement
Earnings Waterfall
ALX Oncology Holdings Inc
Revenue
|
0
USD
|
Operating Expenses
|
-170.3m
USD
|
Operating Income
|
-170.3m
USD
|
Other Expenses
|
9.5m
USD
|
Net Income
|
-160.8m
USD
|
Income Statement
ALX Oncology Holdings Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
5
N/A
|
4
-8%
|
4
-17%
|
2
-34%
|
1
-51%
|
1
-55%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||
Cost of Revenue |
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
-9%
|
0
-18%
|
0
-33%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(20)
|
(21)
|
(27)
|
(34)
|
(44)
|
(54)
|
(59)
|
(74)
|
(84)
|
(94)
|
(112)
|
(124)
|
(127)
|
(135)
|
(138)
|
(154)
|
(170)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(7)
|
(10)
|
(15)
|
(18)
|
(20)
|
(21)
|
(23)
|
(27)
|
(29)
|
(30)
|
(29)
|
(29)
|
(29)
|
(29)
|
(28)
|
|
Research & Development |
(16)
|
(16)
|
(20)
|
(24)
|
(29)
|
(35)
|
(39)
|
(51)
|
(60)
|
(67)
|
(83)
|
(94)
|
(98)
|
(106)
|
(109)
|
(125)
|
(142)
|
|
Operating Income |
(19)
N/A
|
(20)
-5%
|
(27)
-33%
|
(34)
-25%
|
(44)
-30%
|
(53)
-22%
|
(59)
-10%
|
(74)
-25%
|
(84)
-14%
|
(94)
-13%
|
(112)
-19%
|
(124)
-11%
|
(127)
-3%
|
(135)
-6%
|
(138)
-2%
|
(154)
-12%
|
(170)
-10%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
2
|
4
|
6
|
7
|
8
|
9
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
Pre-Tax Income |
(19)
N/A
|
(20)
-6%
|
(28)
-35%
|
(35)
-26%
|
(46)
-31%
|
(54)
-19%
|
(59)
-9%
|
(74)
-24%
|
(83)
-13%
|
(94)
-12%
|
(110)
-18%
|
(121)
-10%
|
(123)
-2%
|
(129)
-5%
|
(130)
-1%
|
(146)
-12%
|
(161)
-10%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(19)
|
(20)
|
(28)
|
(35)
|
(46)
|
(54)
|
(59)
|
(74)
|
(83)
|
(94)
|
(110)
|
(121)
|
(123)
|
(129)
|
(130)
|
(146)
|
(161)
|
|
Net Income (Common) |
(23)
N/A
|
(26)
-10%
|
(34)
-34%
|
(41)
-19%
|
(51)
-24%
|
(58)
-13%
|
(60)
-4%
|
(74)
-23%
|
(83)
-13%
|
(94)
-12%
|
(110)
-18%
|
(121)
-10%
|
(123)
-2%
|
(129)
-5%
|
(130)
-1%
|
(146)
-12%
|
(161)
-10%
|
|
EPS (Diluted) |
-0.67
N/A
|
-0.73
-9%
|
-0.92
-26%
|
-1.1
-20%
|
-2.76
-151%
|
-1.44
+48%
|
-1.49
-3%
|
-1.82
-22%
|
-2.07
-14%
|
-2.31
-12%
|
-2.72
-18%
|
-2.98
-10%
|
-3.03
-2%
|
-3.17
-5%
|
-3.2
-1%
|
-3.54
-11%
|
-3.74
-6%
|